CD8A and mismatch repair cancer syndrome 1: Similarly, Asaka et al. [12] reported that EC patients with mismatch repair deficiency show higher levels of CD8+ T cells, Tregs, and PD-1+ immune cells, while Workel et al. [13] found a correlation between elevated CD8+ PD-1+ lymphocytes and better EC prognosis.